The North America drug modelling software market is expected to reach US$ 4,588.87 million by 2027 from US$ 2,468.17 million in 2019; it is estimated to grow at a CAGR of 8.4% from 2020 to 2027.
Increasing adoption of in-silico modelling tools in drug discovery, and increasing economic burden of drug discovery in the region are the key factors driving the growth of drug modelling software. However, lack of data standardization is the major factor hindering the market growth in North America.
Drug modelling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key role in the development of novel drugs. Software based methods such as molecular modelling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. In addition, appropriate implementation of these techniques may help in reducing cost of drug designing and development.
The discovery and development of new drugs with potential therapeutic applications is a complex, expensive, and time-consuming venture. Considering this challenge, many novel technologies have been developed to increase the efficiency of the drug discovery process. Computational methodologies have become a crucial part of several drug discovery programs. From hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by many pharmaceutical companies. With the help of modelling, existing data can be leveraged to gain insights on product safety and effectiveness. Owing to computational methods efficiency, the FDA have included modelling to support efficient drug development. Nowadays, In-Silico design (computer-aided) is being utilized to expedite and facilitate hit identification, optimize the absorption, distribution, metabolism, and toxicity profile to avoid safety issues. Commonly used in-silico approaches include ligand-based drug design, structure-based drug design, and quantitative structure-activity.
Drugs are essential to stopping more suffering at the hands of Covid-19; at the time of writing, more than 206,000 people have tragically died from the disease. However, in the U.S., to give the technology a push, the ImmunityBio and Microsoft collaborated to support for the research. Supporting Covid-19 drug and vaccine development is the aim of ImmunityBio’s collaboration with Microsoft to leverage the latter’s Azure platform to create a 3D model of SARS-CoV-2’s spike protein. Additionally, Research projects and innovations related to COVID-19 have ramped up quickly across the University of Michigan, spurred by doctors, public health experts, scientists, economists and engineers, and encouraged by research leaders.
With the emerging outbreak of the COVID-19 pandemic, the drug modelling software market is likely to be positively impacted.
Mexico Drug Modelling Software Market, Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA DRUG MODELLING SOFTWARE MARKET SEGMENTATION
By Product Type
- Database
- Software
- Others
By Application
- Drug Discovery and Development
- Computational Physiological Medicine
- Disease Modeling
- Medical Imaging
- Predictive Analysis of Drug Targets
- Simulation Software
- Cellular Simulation
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- Crown Bioscience Inc (JSR life science)
- Chemical Computing Group ULC
- Nimbus Therapeutics
- Schrödinger, Inc
- Leadscope, Inc (Instem)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
roduct Type, Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Drug Modelling Software Market – By Product Type
1.3.2 North America Drug Modelling Software Market – By Application
1.3.3 North America Drug Modelling Software Market – By Country
2. North America Drug Modelling Software Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Drug Modelling Software Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Drug Modelling Software Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Drug Modelling Software Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Modelling Tools in Drug Discovery
5.1.2 Increasing Economic Burden of Drug Discovery
5.2 Key Market Restraints
5.2.1 Lack of Data Standardization
5.3 Key Market Opportunities
5.3.1 Strategic Activities by Market Players
5.4 Future Trends
5.4.1 Growing Adoption of Artificial Intelligence in Drug Discovery
5.5 Impact analysis
6. Drug Modelling Software Market – North America Analysis
6.1 North America Drug Modelling Software Market Revenue Forecasts and Analysis
7. North America Drug Modelling Software Market Analysis and Forecasts To 2027 – By Product Type
7.1 Overview
7.2 North America Drug Modelling Software Market, By Type 2019 & 2027 (%)
7.2.1 North America Drug Modelling Software Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)
7.3 Database
7.3.1 Overview
7.3.2 North America Database Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Software
7.4.1 Overview
7.4.1.1 North America Software Revenue and Forecasts to 2027 (US$ Mn)
7.5 Other Product Types
7.5.1 Overview
7.5.2 North America Other Product Types Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Drug Modelling Software Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 North America Drug Modelling Software Market, By Application 2019 & 2027 (%)
8.2.1 North America Drug Modelling Software Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Drug Discovery and Development
8.3.1 Overview
8.3.2 North America Drug Discovery and Development Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Computational Physiological Medicine
8.4.1 Overview
8.4.2 North America Computational Physiological Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Disease Modelling
8.5.1 Overview
8.5.2 North America Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Medical Imaging
8.6.1 Overview
8.6.2 North America Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Predictive Analysis of Drug Targets
8.7.1 Overview
8.7.2 North America Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Simulation Software
8.8.1 Overview
8.8.2 North America Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)
8.9 Cellular Simulation
8.9.1 Overview
8.9.2 North America Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)
8.10 Others
8.10.1 Overview
8.10.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Drug Modelling Software Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 North America Drug modelling software Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 North America: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.4 North America: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.5 North America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)
9.1.6 US: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.6.3 US: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.7 Canada: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Canada: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.8 Mexico: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Mexico: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on North America Drug Modelling Software Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Crown Bioscience Inc (JSR life science)
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Chemical Computing Group ULC.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Nimbus Therapeutics
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Schrödinger, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Leadscope, Inc (Instem)
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Drug Modelling Software Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)
Table 2. North America Drug Modelling Software Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 4. North America: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. US: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 6. US: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Mexico: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. Glossary of Terms, Drug Modelling Software Market
LIST OF FIGURES
Figure 1. Drug Modelling Software Market Segmentation
Figure 2. North America Drug Modelling Software Market Overview
Figure 3. Software Segment Held Largest Share of Drug Modelling Software Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Drug Modelling Software Market - Leading Country Markets (US$ Mn)
Figure 6. Drug Modelling Software Market - North America PEST Analysis
Figure 7. Drug Modelling Software Market Impact Analysis of Driver and Restraints
Figure 8. North America Drug Modelling Software Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Drug Modelling Software Market, By Type 2019 & 2027 (%)
Figure 10. North America Database Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Other Product Types Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Drug Modelling Software Market, By Application 2019 & 2027 (%)
Figure 14. North America Drug Discovery and Development Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Computational Physiological Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. North America Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)
Figure 24. North America: Drug Modelling Software Market, by Country, 2019 & 2027 (%)
Figure 25. US: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Canada: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Mexico: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic In North American Country Markets
The List of Companies - North America Drug Modelling Software Market
- Crown Bioscience Inc (JSR life science)
- Chemical Computing Group ULC
- Nimbus Therapeutics
- Schrödinger, Inc
- Leadscope, Inc (Instem)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to North America Drug Modelling Software Market
Sep 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Sep 2020